Are markers of proliferation valuable in the histological assessment of pituitary tumours?

Are markers of proliferation valuable in the histological assessment of pituitary tumours?

The prediction of tumour behaviour and response to treatment has led to interest in the assessment of the proliferative potential of tumours. Pituitary tumours are usually histologically benign but are capable of aggressive growth and local invasion, although distant metastasis is limited to the ver...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Turner, H, Wass, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	1999

Documenti analoghi

Pituitary tumours in the elderly.
di: Turner, H, et al.
Pubblicazione: (1997)

Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.
di: Turner, H, et al.
Pubblicazione: (2000)

Pituitary tumours in the elderly: a 20 year experience.
di: Turner, H, et al.
Pubblicazione: (1999)

Non-adenomatous pituitary tumours.
di: Karavitaki, N, et al.
Pubblicazione: (2009)

Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.
di: McCormack, A, et al.
Pubblicazione: (2011)

Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
di: McCormack, A, et al.
Pubblicazione: (2011)

The enhanced peroxidase one step method increases sensitivity for detection of Ki-67 in pituitary tumours.
di: Turner, H, et al.
Pubblicazione: (1999)

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary tumour apoplexy.
di: Capatina, C, et al.
Pubblicazione: (2014)

Second brain tumour after treatment for pituitary adenoma.
di: Wass, J, et al.
Pubblicazione: (1992)

Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
di: Bradley, K, et al.
Pubblicazione: (2003)

An account of the quality of life of patients after treatment for non-functioning pituitary tumours.
di: Page, R, et al.
Pubblicazione: (1997)

The effect of dopamine agonist therapy on large functionless pituitary tumours.
di: Grossman, A, et al.
Pubblicazione: (1985)

Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
di: Turner, H, et al.
Pubblicazione: (2000)

Angiogenesis in pituitary adenomas and the normal pituitary gland.
di: Turner, H, et al.
Pubblicazione: (2000)

The importance of locating a good pituitary surgeon.
di: Wass, J, et al.
Pubblicazione: (1999)

Pituitary apoplexy in non-functioning pituitary adenomas: Long term follow up is important because of significant numbers of tumour recurrences
di: Pal, A, et al.
Pubblicazione: (2011)

Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences.
di: Pal, A, et al.
Pubblicazione: (2011)

Malignant pituitary tumours.
di: Kaltsas, G, et al.
Pubblicazione: (1998)

Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas.
di: de la Torre, N, et al.
Pubblicazione: (2004)

The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours.
di: Harris, P, et al.
Pubblicazione: (1989)

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.
di: Karavitaki, N, et al.
Pubblicazione: (2010)

Architects of Pituitary Tumour Growth
di: Maria Eugenia Sabatino, et al.
Pubblicazione: (2022-06-01)

Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
di: Karavitaki, N, et al.
Pubblicazione: (2006)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
di: Pedro Marques, et al.
Pubblicazione: (2019-11-01)

Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
di: Simpson, D, et al.
Pubblicazione: (2001)

Role of matrix metalloproteinase 9 in pituitary tumor behavior.
di: Turner, H, et al.
Pubblicazione: (2000)

The diagnosis and management of parasellar tumours of the pituitary.
di: Kaltsas, G, et al.
Pubblicazione: (2008)

Clinical and Epidemiological Characteristics of Pituitary Tumours using a Web-based Pituitary Tumour Registry in Oman
di: Abdullah Al-Futaisi, et al.
Pubblicazione: (2007-04-01)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
di: Arnold, J, et al.
Pubblicazione: (2008)

Pituitary tumours: surgery or medical shrinkage.
di: Grossman, A
Pubblicazione: (1986)

Visual status in suprasellar pituitary tumours
di: Kaur Apjit, et al.
Pubblicazione: (1995-01-01)

Costs and Its Determinants in Pituitary Tumour Surgery
di: Alies J. Dekkers, et al.
Pubblicazione: (2022-07-01)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
di: Ahmad Saad, Fathinul Fikri, et al.
Pubblicazione: (2015)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
di: Arnold, JR, et al.
Pubblicazione: (2009)

Nonfunctioning pituitary adenomas: the Oxford experience.
di: Wass, J, et al.
Pubblicazione: (2009)

Expression of annexins 1 and 5 in human pituitary tumours
di: Mulla, A, et al.
Pubblicazione: (2000)

Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
di: Turner, H, et al.
Pubblicazione: (2000)

Treatment of pituitary tumors: history.
di: Thanabalasingham, G, et al.
Pubblicazione: (2005)

Histological characteristics and markers of proliferation and differentiation in rat brain with experimental glioma
di: Ristić Slavica, et al.
Pubblicazione: (2014-01-01)

Role of regulatory factors in pituitary tumour formation.
di: Korbonits, M, et al.
Pubblicazione: (2004)